Company Filing History:
Years Active: 2018
Title: André Fisahn: Innovator in Alzheimer's Disease Research
Introduction
André Fisahn is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of molecular biochemistry and medicine, particularly in the context of Alzheimer's disease.
Latest Patents
His most recent patent is titled "Ligands for prevention of neurotoxicity of the Alzheimer's disease related amyloid-beta peptide." This invention focuses on ligands that comprise modified amino acid residues, which target the amyloid-β peptide associated with Alzheimer's disease. The aim is to prevent aggregation and neurotoxicity, offering potential use as drugs for the treatment of Alzheimer's disease.
Career Highlights
André Fisahn is currently associated with Alphabeta AB, where he continues to advance his research and innovations. His work is pivotal in developing therapeutic strategies for neurodegenerative diseases.
Collaborations
He collaborates with esteemed colleagues, including Roger Strömberg and Dmytro Honcharenko, to further enhance the impact of his research.
Conclusion
André Fisahn's contributions to Alzheimer's disease research through his innovative patents and collaborations highlight his commitment to improving medical science. His work is essential in the ongoing fight against neurodegenerative diseases.